GORGANI, N. N.; KIM, K. H. S.; FREE, W. L.; AFKHAM, M.; HENSON, J. D.; SHAMANNA, P.; AJDARI, S. .; KAHN, C. R. .; HIRST, T. R. .; BARNETT, A. H. .; PAUL, S. K. . OZ101, an oligofructose prebiotic, may prolong sulphonylurea efficcy in patients with type 2 diabetes: a pilot study: OZ101 and sulphonylurea-mediated glycaemic control. Journal of Current Medical Research and Opinion, [S. l.], v. 5, n. 06, p. 1235–1251, 2022. DOI: 10.52845/CMRO/2022/5-6-2. Disponível em: https://cmro.in/index.php/jcmro/article/view/528. Acesso em: 20 may. 2024.